A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing.

Cardiac sympathetic function was assessed by measuring the coronary sinus overflow of noradrenaline and dopamine at rest and during supine exercise in eight patients with high degree atrioventricular block treated with dual chamber pacemakers (DDD). Patients exercised (30-60 W) during both ventricular inhibited (VVI) and atrial synchronous (VAT) pacing. During exercise cardiac output increased less markedly in the VVI mode than in the VAT mode. The cardiac output response was entirely stroke volume dependent in the VVI mode and mainly heart rate dependent in the VAT mode. Coronary sinus noradrenaline concentrations were higher in the VVI mode at rest and during exercise. Noradrenaline overflow from the heart was enhanced during VVI pacing and increased from about 100 pmol/min (17 ng/min) at rest to 1087 pmol/min during exercise (60 W) in the VVI mode and 545 pmol/min in the VAT mode. Dopamine overflow from the heart was less than 5 pmol/at rest but increased 2-5 fold during exercise. Also arterial concentrations of catecholamine increased more during exercise in the VVI mode, but the differences between pacing modes were less pronounced. Circulating adrenaline seems to be of little importance for cardiac function under these conditions; in healthy individuals the arterial concentrations of adrenaline attained in this study have small effects. Cardiac noradrenaline overflow correlated with pulmonary capillary venous pressures and atrial rates in both pacing modes, indicating a relation between cardiac sympathetic activity and cardiac function. Enhanced cardiac release of noradrenaline may increase cardiac contractility and thereby partially compensate for the lack of heart rate responsiveness to exercise during VVI pacing.

[1]  M. Demany,et al.  Coronary artery visualization and coronary surgery--a word of caution. , 1966, American heart journal.

[2]  P. Samet,et al.  Hemodynamic sequelae of atrial, ventricular, and sequential atrioventricular pacing in cardiac patients. , 1966, American heart journal.

[3]  H. Swan,et al.  Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in Man , 1971, Circulation.

[4]  L. I. Goldberg,et al.  Cardiovascular and renal actions of dopamine: potential clinical applications. , 1972, Pharmacological reviews.

[5]  R. Nadeau,et al.  Correlation between the Response of the Heart to Sympathetic Stimulation and the Release of Endogenous Catecholamines into the Coronary Sinus of the Dog , 1975, Circulation research.

[6]  M. N. Levy,et al.  Correlation of the mechanical responses of the heart with the norepinephrine overflow during cardiac sympathetic neural stimulation in the dog. , 1977, Cardiovascular research.

[7]  N. Christensen,et al.  Determinants of coronary sinus noradrenaline in patients with ischaemic heart disease: coronary sinus catecholamine concentration in relation to arterial catecholamine concentration, pulmonary artery oxygen saturation and left ventricular end-diastolic pressure. , 1978, Cardiovascular research.

[8]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[9]  P. Hjemdahl,et al.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.

[10]  P. Cryer.  Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. , 1980, The New England journal of medicine.

[11]  G. Daughters,et al.  Exercise response of the denervated heart in long-term cardiac transplant recipients. , 1980, The American journal of cardiology.

[12]  D. Goldstein,et al.  Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. , 1981, The American journal of cardiology.

[13]  L. Rydén,et al.  A Comparison of the Acute and Long‐term Hemodynamic Effects of Ventricular Inhibited and Atrial Synchronous Ventricular Inhibited Pacing , 1982, Circulation.

[14]  D C Harrison,et al.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.

[15]  J. Halter,et al.  Cardiac uptake and secretion of catecholamines during adrenergic stimulation in vivo. , 1982, The American journal of physiology.

[16]  J. Cohn,et al.  Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.

[17]  B. Wallin,et al.  Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. , 1983, Hypertension.

[18]  Cardiac and pulmonary norepinephrine release and removal in the dog. , 1983, Circulation research.

[19]  S. Snider,et al.  Dopamine: an important neurohormone of the sympathoadrenal system. Significance of increased peripheral dopamine release for the human stress response and hypertension. , 1983, Endocrine reviews.

[20]  D. Bone,et al.  Left ventricular volumes with ventricular inhibited and atrial triggered ventricular pacing. , 2009, Acta medica Scandinavica.

[21]  S. Pehrsson,et al.  Left ventricular function after long-term treatment with ventricular inhibited compared to atrial triggered ventricular pacing. , 2009, Acta medica Scandinavica.

[22]  J. Cohn,et al.  Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.

[23]  P Hjemdahl,et al.  Differentiated sympathetic activation during mental stress evoked by the Stroop test. , 1984, Acta physiologica Scandinavica. Supplementum.

[24]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[25]  G. Jennings,et al.  Contribution of individual organs to total noradrenaline release in humans. , 1984, Acta physiologica Scandinavica. Supplementum.

[26]  P. Hjemdahl,et al.  Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ. , 1984, Acta physiologica Scandinavica.

[27]  Arthur C. Guyton,et al.  Handbook of Physiology—The Cardiovascular System , 1985 .

[28]  Heart Rate Modulates the Disposition of Neurally Released Norepinephrine in Cardiac Tissues , 1985, Circulation research.

[29]  P Hjemdahl,et al.  Renal extraction of endogenous and radiolabelled catecholamines in the dog. , 1986, Acta physiologica Scandinavica.

[30]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[31]  P. Hjemdahl,et al.  Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans. , 1986, Clinical science.

[32]  G. Flaker,et al.  Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. , 1986, Journal of the American College of Cardiology.

[33]  P. Hjemdahl.  [63] Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection , 1987 .

[34]  P. Hjemdahl.  Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. , 1987, Methods in enzymology.

[35]  I Ninomiya,et al.  [Neural control of the heart]. , 1987, Kokyu to junkan. Respiration & circulation.